Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial
Pelletier, G × Ducreux, M Gay, F Luboinski, M Hagege, H Dao, T Van Steenbergen, Werner Buffet, C Rougier, P Adler, M Pignon, JP Roche, A #
Munksgaard int publ ltd
Journal of hepatology vol:29 issue:1 pages:129-134
Background/Aims: Lipiodol chemoembolization is a widely used method of treatment in patients with unresectable hepatocellular carcinoma, but its efficacy is still debated. The aim of our study was to assess the efficacy of lipiodol chemoembolization in patients with unresectable hepatocellular carcinoma.